Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease
{{output}}
Non-alcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease in the United States, affecting approximately 1 out of every 4 Americans. NAFLD is a spectrum of disorders including simple steatosis, characterized by the presence of hepat... ...
